TLP Group’s Precigen PGEN Stock Holding History

TLP Group’s Portfolio PGEN Stock Details PGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-14,533	Closed	-$276K	–	696
2017 Q3	$276K	Buy	14,533 +2,837	+24%	+$58.4K	0.17%	143
2017 Q2	$282K	Buy	11,696 +11,602	+12,343%	+$254K	0.26%	36
2017 Q1	$2K	Buy	+94	New	+$2.1K	﹤0.01%	326
2016 Q4	–	Sell	-1,797	Closed	-$50K	–	349
2016 Q3	$50K	Buy	+1,797	New	+$47.5K	0.05%	266
2016 Q2	–	Sell	-18,667	Closed	-$627K	–	394
2016 Q1	$627K	Buy	+18,667	New	+$588K	0.38%	36

Other funds holding PGEN

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

TLP Group's PGEN Position: Q4 2017 in Review

TLP Group sold out of Precigen (PGEN) in Q4 2017, closing a stake of 14,533 shares — an estimated $276K sold.

TLP Group first reported a position in PGEN in Q1 2016 and held it in 5 quarters. The position peaked at $627K in Q1 2016. 162 funds tracked by Wall St. Rank hold PGEN as of Q4 2017.

TLP Group reported no remaining Precigen position as of Q4 2017 after selling out during the quarter.
TLP Group sold 14,533 Precigen shares in Q4 2017, an estimated $276K.
TLP Group first reported a position in Precigen in Q1 2016 and held it in 5 quarters.
TLP Group's Precigen position peaked at $627K in Q1 2016.
162 funds tracked by Wall St. Rank held Precigen as of Q4 2017.

Based on TLP Group's 13F filing for Q4 2017, filed 14 Feb 2018.